Dactilus
Oral hypoglycemic agent. Highly potent, selective and reversible inhibitor of sodium–glucose cotransporter 2 (SGLT2). Indicated for the treatment of type 2 diabetes (T2D).
Therapeutic Area
Oral Antidiabetics + Oral Hypoglycemic
Active Ingredient
Daplagliflozin
Line
Cardiometabolism + Diabetes + Endocrinology + Medical Clinic
Dosage forms
10 mg x 28 coated tablets
